Erasca, Inc. (ERAS) stock
ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.76−0.13 (-0.94%)
Close on Nov 18, 2026Market cap $4.81BP/E –Yield 0.00%
Erasca operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Erasca's operating income for the twelve months ending Jun 30, 2026 was -$302.68M. For fiscal 2025 it was -$140.91M. The highest annual figure on record is -$109.25M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$140.91M | – |
| FY2024 | Dec 31, 2024 | -$179.59M | – |
| FY2023 | Dec 31, 2023 | -$141.53M | – |
| FY2022 | Dec 31, 2022 | -$247.45M | – |
| FY2021 | Dec 31, 2021 | -$124.88M | – |
| FY2020 | Dec 31, 2020 | -$109.25M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$47.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$187.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$32.60M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$38.13M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.63M | – |
| Q4 FY2024 | Dec 31, 2024 | -$35.71M | – |
| Q3 FY2024 | Sep 30, 2024 | -$37.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$67.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$38.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$33.87M | – |
| Q3 FY2023 | Sep 30, 2023 | -$34.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$35.97M | – |
| Q1 FY2023 | Mar 31, 2023 | -$37.03M | – |
| Q4 FY2022 | Dec 31, 2022 | -$138.08M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.96M | – |
| Q2 FY2022 | Jun 30, 2022 | -$35.91M | – |
| Q1 FY2022 | Mar 31, 2022 | -$36.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$31.05M | – |
| Q3 FY2021 | Sep 30, 2021 | -$46.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$28.18M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.61M | – |
| Q4 FY2020 | Dec 31, 2020 | -$66.97M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.28M | – |
See a number that looks wrong?